DENGUE
(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines & Drugs)
3996.
Barrett AD. Current status of flavivirus vaccines. Ann N Y Acad Sci
2001 Dec;951:262-71
3997.
Blaney JE Jr, Johnson DH, Firestone CY, Hanson CT, Murphy BR, Whitehead
SS. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are
temperature sensitive in vero cells or human liver cells and attenuated in mice.
J Virol 2001 Oct;75(20):9731-40
3998.
Chang GJ, Davis BS, Hunt AR, Holmes DA, Kuno G. Flavivirus DNA vaccines:
current status and potential. Ann N Y Acad Sci 2001 Dec;951:272-85
3999.
Cuzzubbo AJ, Endy TP, Nisalak A, Kalayanarooj S, Vaughn DW, Ogata SA,
Clements DE, Devine PL. Use of recombinant envelope proteins for serological
diagnosis of Dengue virus infection in an immunochromatographic assay. Clin
Diagn Lab Immunol 2001 Nov;8(6):1150-5
4000.
Gomber S, Ramachandra n V G, Satish Kumar, Agarwal K N, Gupta P, Gupta P,
Dewan D K: Hematological observation as diagnostic markers in dengue hemorrhagic
fever. Indian Pediat 2001, 38(5), 477-81.(015304). Aug 1, 2001.
4001.
Huang JL, Huang JH, Shyu RH, Teng CW, Lin YL, Kuo MD, Yao CW, Shaio MF.
High level expression of recombinant dengue viral NS-1 protein and its potential
use as a diagnostic antigen. J Med Virol 2001
Nov;65(3):553-60
4002.
Openshaw PJ, Culley FJ, Olszewska W. Immunopathogenesis of
vaccine-enhanced RSV disease. Vaccine 2001
Oct 15;20 Suppl 1:S27-31
4003.
Pea L, Roda L, Moll F. Desmopressin treatment for a case of dengue
hemorrhagic fever/dengue shock syndrome. Clin Infect Dis
2001 Nov 1;33(9):1611-2
4004 Troyer JM, Hanley KA, Whitehead SS, Strickman D, Karron RA, Durbin AP, Murphy BR. A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes. Am J Trop Med Hyg 2001 Nov;65(5):414-9
Back |